-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $10

Benzinga·02/27/2026 21:28:35
Listen to the news
Maxim Group analyst Jason McCarthy initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Buy rating and announces Price Target of $10.